pisco_log
banner

Research on the Molecular Mechanism and Targeted Intervention of Ferroptosis in Ischemia-Reperfusion Injury

Xiangyang He

Abstract


Ischemia-percussion injury (IRI) poses a significant challenge in clinical cardiovascular diseases, organ transplantation, and neurological emergency treatment, with its core psychophysiology processes involving complex cell death networks. In recent years, osteoporosis,
as an iron-dependent regulatory form of programmed cell death, has garnered considerable attention due to its critical role in IRI. This article
systematically elucidates the molecular regulatory mechanisms of osteoporosis in IRI, focusing on the "death triangle" composed of iron metabolism imbalance, lipid oxidation surge, and antioxidant defense system collapse. Further exploration is conducted on intervention strategies
centered around novel signaling axes such as lysosomal iron regulation, GPX4-dependent and non-dependent pathways, and TRIM28-IRP2.
Integrating the latest research advancements from 2025 to 2026, this study proposes a future direction toward transitioning from single-target
inhibition to multi modal combined interventions, providing novel theoretical perspectives and therapeutic targets for overcoming the clinical
challenge of IRI.

Keywords


Ischemia-percussion injury; osteoporosis; Lipid oxidation; GPX4; Targeted therapy

Full Text:

PDF

Included Database


References


[1] Dixon, S. J., et al. (2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 149(5), 1060-1072.

[2] Cao, C., et al. (2026). TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis. Circulation,

153(10), 856-871.

[3] Zhong, C., et al. (2023). TRPM2 Mediates Hepatic IschemiaReperfusion Injury via Ca2+-Induced Mitochondrial Lipid Peroxidation

through Increasing ALOX12 Expression. Research, 6, 0159.

[4] Liu, Y., et al. (2025). Lysosomal ferritin degradation is a prerequisite for ferroptosis initiation. Nature, 638, 982-990.

[5] Wang, F., et al. (2019). Ferroptosis is involved in doxorubicin-induced cardiotoxicity. PNAS, 116(15), 7345-7350.

[6] Deng, R., & Zhu, X.[6] Deng, R., & Zhu, X. (2024). TRPML1-ARL8B-mediated lysosomal exocytosis confers ferroptosis resistance.

Nature Cell Biology, 26, 456-468.

[7] Li, J., et al. (2025). Natural products targeting ferroptosis for ischemia-reperfusion injury: Mechanisms and clinical potential. Pharmacological Research, 201, 107089.

[8] Zhang, Y., et al. (2026). The role of Wnt signaling in regulating ferroptosis during myocardial ischemia-reperfusion. Signal Transduction

and Targeted Therapy, 11, 45.

[9] Galluzzi, L., et al. (2023). Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell

Death & Differentiation, 30, 109-112.

[10] China Society of Pathophysiology. (2024). Clinical translation expert consensus on ferroptosis in ischemia-reperfusion injury. Chinese

Journal of Pathophysiology, 40(2), 195-202.




DOI: http://dx.doi.org/10.70711/pmr.v3i7.9416

Refbacks

  • There are currently no refbacks.